(Q61640358)
Statements
The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept (English)
Dirkjan van Schaardenburg
Anna Jamnitski
Geertje M Bartelds
Michael T Nurmohamed
Steven O Stapel
Ben A C Dijkmans
Lucien Aarden
Gerrit Jan Wolbink
10 November 2010